ArticleActa neuropathologica communications2026
Patient-derived glioblastoma cultures preserve respiration phenotypes during ex vivo maintenance and show sex-associated differences in migration.
Article in Acta neuropathologica communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Glioblastoma (GBM) is a highly heterogeneous, invasive brain tumor with profound metabolic plasticity. Patient-derived cultures provide valuable preclinical models, yet the stability and clinical relevance of their metabolic phenotypes during ex vivo maintenance remain unclear. Here, we performed longitudinal functional profiling of mitochondrial respiration, substrate utilization, and migration in primary patient-derived GBM cultures at one and five weeks ex vivo using Seahorse Bioanalyzer assays and wound-healing assays, complemented by exploratory integration with routine clinical parameters (MGMT promoter methylation, p53 expression, sex, and age). Early profiling identified two mitochondrial subgroups distinguished by spare and maximal respiratory capacity, with MGMT promoter methylation observed exclusively in the high-respiration cluster. Over time, most cultures retained their initial phenotype, whereas a subset transitioned from low to high respiration, indicating dynamic adaptation under standardized conditions. Extended culture was accompanied by patient-specific shifts in fuel utilization, including increased glutamine dependency and reduced inter-sample variability in glucose and fatty-acid parameters. Exploratory analyses suggested an association between higher age and lower fatty-acid oxidation capacity and indicated constrained fatty-acid dependency in p53-positive cultures. Migration assays revealed marked inter-sample heterogeneity and a 2-6 times faster gap closure in male-derived than female-derived cultures. Notably, early migratory behavior showed no strong association with OCR-defined metabolic state, and early fuel-flex parameters did not recapitulate OCR cluster structure. Together, these data provide a standardized longitudinal functional benchmark showing that patient-derived GBM cultures preserve intrinsic metabolic heterogeneity while undergoing time-dependent adaptation, and that migration represents an additional, partially independent functional axis. These findings are hypothesis-generating and support stratified, time-sensitive follow-up studies of metabolic and invasive phenotypes in GBM.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.